| http://www.w3.org/ns/prov#value | - Once they had figured out the molecular pathway responsible for poor wound healing in diabetic tissue, the researchers realized that deferoxamine ??? an off-patent drug that binds to iron and removes it from the body ??? might help to short-circuit this pathway. (Deferoxamine has been used for decades to treat diseases such as thalassemia in which toxic levels of iron accumulate in tissues.)
|
